GBCS (Selectis Health) Cyclically Adjusted Revenue per Share: $8.66 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GBCS Selectis Health Inc GBCS
43 GF Score
Price $5.74
GF Value $1.78
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Selectis Health Cyclically Adjusted Revenue per Share?

Selectis Health GBCS +0.53% 43 Cyclically Adjusted Revenue per Share is $8.66 as of Jun. 2026. GuruFocus rates GBCS with a GF Score™ of 43/100 and a GF Value™ of $1.78 (Significantly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Selectis Health's adjusted revenue per share for the three months ended in Jun. 2026 was $1.368. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $8.66 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Selectis Health's average Cyclically Adjusted Revenue Growth Rate was 15.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 23.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 22.40% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 1.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Selectis Health was 25.90% per year. The lowest was -16.40% per year. And the median was -12.00% per year.

As of today (2026-09-06), Selectis Health's current stock price is $5.74. Selectis Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was $8.66. Selectis Health's Cyclically Adjusted PS Ratio of today is 0.66.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Selectis Health was 2.34. The lowest was 0.18. And the median was 0.75.


Selectis Health  (OTCPK:GBCS) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Selectis Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=5.74/8.66
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Selectis Health was 2.34. The lowest was 0.18. And the median was 0.75.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Selectis Health Cyclically Adjusted Revenue per Share Related Terms


Selectis Health Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Selectis Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Selectis Health Cyclically Adjusted Revenue per Share Chart

Selectis Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.42 4.35 5.49 6.83 8.15

Selectis Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.52 7.86 8.15 8.48 8.66

GBCS vs ADIA, CCM, SYRA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Selectis Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Selectis Health Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Selectis Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Selectis Health's Cyclically Adjusted PS Ratio falls into.


GBCS
43GF Score
Selectis Health Inc GBCS
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Selectis Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Selectis Health's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.368/333.9520*333.9520
=1.368

Current CPI (Jun. 2026) = 333.9520.

Selectis Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.358 241.428 0.495
201612 0.219 241.432 0.303
201703 0.310 243.801 0.425
201706 0.299 244.955 0.408
201709 0.289 246.819 0.391
201712 0.314 246.524 0.425
201803 0.305 249.554 0.408
201806 0.335 251.989 0.444
201809 0.327 252.439 0.433
201812 0.380 251.233 0.505
201903 0.474 254.202 0.623
201906 0.590 256.143 0.769
201909 0.725 256.759 0.943
201912 0.747 256.974 0.971
202003 1.404 258.115 1.817
202006 1.845 257.797 2.390
202009 2.037 260.280 2.614
202012 1.380 260.474 1.769
202103 2.087 264.877 2.631
202106 2.236 271.696 2.748
202109 2.591 274.310 3.154
202112 3.222 278.802 3.859
202203 3.119 287.504 3.623
202206 3.087 296.311 3.479
202209 3.042 296.808 3.423
202212 3.410 296.797 3.837
202303 2.876 301.836 3.182
202306 2.664 305.109 2.916
202309 2.961 307.789 3.213
202312 3.012 306.746 3.279
202403 3.095 312.332 3.309
202406 3.125 314.175 3.322
202409 3.266 315.301 3.459
202412 3.390 315.605 3.587
202503 3.419 319.799 3.570
202506 3.404 322.561 3.524
202509 3.534 324.800 3.634
202512 3.154 324.054 3.250
202603 2.117 330.213 2.141
202606 1.368 333.952 1.368

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $8.66 mean?
Selectis Health (GBCS) has a Cyclically Adjusted Revenue per Share of $8.66 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Selectis Health and its competitors.
Is Selectis Health's Cyclically Adjusted Revenue per Share too high?
Selectis Health's current Cyclically Adjusted Revenue per Share is $8.66. Overall, Selectis Health has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selectis Health's Cyclically Adjusted Revenue per Share compare to ADIA and CCM?
Selectis Health's Cyclically Adjusted Revenue per Share of $8.66 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Selectis Health and its competitors. Selectis Health's current Cyclically Adjusted Revenue per Share is $8.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selectis Health stock overvalued right now?
Based on GuruFocus' analysis, Selectis Health (GBCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.78, compared to a current price of $5.74 — trading 222.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $8.66. Selectis Health's overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Selectis Health (GBCS), the current Cyclically Adjusted Revenue per Share is $8.66 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Selectis Health (GBCS) Overvalued in 2026?

Based on GuruFocus' analysis, Selectis Health stock appears to be overvalued. The current stock price of $5.74 is trading 222.5% above its estimated GF Value™ of $1.78. GuruFocus considers Selectis Health to be Significantly Overvalued.

Key valuation signals for GBCS:

  • Cyclically Adjusted Revenue per Share: $8.66
  • GF Value™: $1.78 vs. price of $5.74 (222.5% above fair value)
  • GF Score™: 43/100 with 5 warning signs

No single metric tells the full story. See the GBCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Selectis Health Business Description

Address 600 17th Street, Suite 284, Denver, CO, USA, 80202
Selectis Health Inc owns and operates medical care facilities in the healthcare industry. The company acquires, develops, leases, and manages healthcare real estate and provides healthcare operations through its wholly-owned subsidiaries. The portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. It makes investments within the healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008, which represents investments in senior housing operations, and (vi) owning healthcare operations.
43GF Score

Get the complete analysis for GBCS

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.74
Price
$1.78
GF Value